Journal of Vaccines & Vaccination

Globalization of antimicrobial resistance: Challenges and response in developing world

International Conference & Exhibition on Vaccines & Vaccination

22-24 Nov 2011 Philadelphia Airport Marriott, USA

Dave N G, Trivedi A V, Jani V R, Raval D A, Mevada M S and Dave S M

Scientific Tracks Abstracts: J Vaccines Vaccin

Abstract:

Infectious diseases are a global concern and the second commonest cause of death worldwide. Of the annual 12 million deaths, 95% occur in the developing countries, where prevention and control policies are either non-existent, poorly adapted or insuffi ciently funded by governments. Antimicrobial resistance is one of the major challenges of public health in developing countries with impact on increasing morbidity and mortality, the period of infectiousness, adverse reactions, length of hospital stay and costs. Overuse, misuse and non use of antimicrobials are identifi ed as key factors in the emergence of antimicrobial resistance. Other factors contributing to resistance are use of antimicrobials in the veterinary area, globalization and lack of antibiotic stewardship programs. Poverty, poor sanitation, malnutrition, inadequate access to antimicrobials and health care systems, war and economic disturbances all signifi cantly multiply the burden of antimicrobial resistance i ssue. In developing countries antimicrobials are frequently available over the counter in pharmacies. Th e quality and potency of antibiotics are oft en suspected, with unregulated import, registration and distribution. Th e basic requirement for controlling antimicrobial resistance in develo ping countries are multifaceted strategies, which include: increase awareness of the antibiotic resistance problem, surveillance of antimicrobial resistance and usage, prudent antimicrobial use in community and hospitals, infection control measures, ongoing education, research and inter sectorial coordination. Th e most important key to successful implementation of interventions in these countries is a strong governmental commitment and support. Focusing on containment of antimicrobial resistance, countries with limited resources can improve the quality of healthcare in the future.

Biography :

Lul Raka, MD-PhD is Professor of Medical Microbiology at the University of Prishtina, Kosovo. He also works as Medical microbiologist at the National Institute of Public Health of Kosova. Currently he is Director of the National Committee for health care-associated infections and antimicrobial resistance at the Ministry of Health of Kosova Government. He has published more than 20 papers in reputed journals in the fi eld of infection control and antimicrobial resistance